Report for McKeage K

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Trelagliptin: First Global Approval - McKeage_2015_Drugs_75_1161
Author(s) : McKeage K
Ref : Drugs , 75 :1161 , 2015
Abstract : McKeage_2015_Drugs_75_1161
ESTHER : McKeage_2015_Drugs_75_1161
PubMedSearch : McKeage_2015_Drugs_75_1161
PubMedID: 26115728

Title : Spotlight on memantine in moderate to severe Alzheimer's disease - McKeage_2010_Drugs.Aging_27_177
Author(s) : McKeage K
Ref : Drugs & Aging , 27 :177 , 2010
Abstract : McKeage_2010_Drugs.Aging_27_177
ESTHER : McKeage_2010_Drugs.Aging_27_177
PubMedSearch : McKeage_2010_Drugs.Aging_27_177
PubMedID: 20104942

Title : Memantine: a review of its use in moderate to severe Alzheimer's disease - McKeage_2009_CNS.Drugs_23_881
Author(s) : McKeage K
Ref : CNS Drugs , 23 :881 , 2009
Abstract : McKeage_2009_CNS.Drugs_23_881
ESTHER : McKeage_2009_CNS.Drugs_23_881
PubMedSearch : McKeage_2009_CNS.Drugs_23_881
PubMedID: 19739697